Hepatology, 1527-3350

Journal

More filtering options
  1. 2016
  2. A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice

    Lundbäck, P., Lea, J. D., Sowinska, A., Ottosson, L., Fürst, C. M., Steen, J., Aulin, C., Clarke, J. I., Kipar, A., Klevenvall, L., Yang, H., Palmblad, K., Park, B. K., Tracey, K. J., Anna M. Blom, Andersson, U., Antoine, D. J. & Erlandsson Harris, H., 2016 Nov 1, In : Hepatology. 64, 5, p. 1699-1710 12 p.

    Research output: Contribution to journalArticle

  3. 2014
  4. CYLD regulates HGF expression in hepatic stellate cells via interaction with HDAC7.

    Rajeswara, P. R., Dorn, C., Hellerbrand, C. & Ramin Massoumi, 2014, In : Hepatology. 60, 3, p. 1066-1081

    Research output: Contribution to journalArticle

  5. Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer

    Aleksandrova, K., Boeing, H., Noethlings, U., Jenab, M., Fedirko, V., Kaaks, R., Lukanova, A., Trichopoulou, A., Trichopoulos, D., Boffetta, P., Trepo, E., Westhpal, S., Duarte-Salles, T., Stepien, M., Overvad, K., Tjonneland, A., Halkjaer, J., Boutron-Ruault, M-C., Dossus, L., Racine, A. & 28 others, Lagiou, P., Bamia, C., Benetou, V., Agnoli, C., Palli, D., Panico, S., Tumino, R., Vineis, P., Bueno-De-Mesquita, B., Peeters, P. H., Gram, I. T., Lund, E., Weiderpass, E., Quiros, J. R., Agudo, A., Sanchez, M-J., Gavrila, D., Barricarte, A., Dorronsoro, M., Bodil Ohlsson, Lindkvist, B., Johansson, A., Sund, M., Khaw, K-T., Wareham, N., Travis, R. C., Riboli, E. & Pischon, T., 2014, In : Hepatology. 60, 3, p. 858-871

    Research output: Contribution to journalArticle

  6. Prediagnostic Circulating Vitamin D Levels and Risk of Hepatocellular Carcinoma in European Populations: A Nested Case-Control Study

    Fedirko, V., Duarte-Salles, T., Bamia, C., Trichopoulou, A., Aleksandrova, K., Trichopoulos, D., Trepo, E., Tjonneland, A., Olsen, A., Overvad, K., Boutron-Ruault, M-C., Clavel-Chapelon, F., Kvaskoff, M., Kuehn, T., Lukanova, A., Boeing, H., Buijsse, B., Klinaki, E., Tsimakidi, C., Naccarati, A. & 29 others, Tagliabue, G., Panico, S., Tumino, R., Palli, D., Bueno-de-Mesquita, H. B., Siersema, P. D., Peters, P. H., Lund, E., Brustad, M., Olsen, K. S., Weiderpass, E., Zamora-Ros, R., Sanchez, M-J., Ardanaz, E., Amiano, P., Navarro, C., Ramon Quiros, J., Werner, M., Sund, M., Lindkvist, B., Johan Malm, Travis, R. C., Khaw, K-T., Stepien, M., Scalbert, A., Romieu, I., Lagiou, P., Riboli, E. & Jenab, M., 2014, In : Hepatology. 60, 4, p. 1222-1230

    Research output: Contribution to journalArticle

  7. The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis

    Duffy, D., Mamdouh, R., Laird, M., Soneson, C., Le Fouler, L., El-Daly, M., Casrouge, A., Decalf, J., Abbas, A., Eldin, N. S., Fontes, M., Abdel-Hamid, M., Mohamed, M. K., Rafik, M., Fontanet, A. & Albert, M. L., 2014, In : Hepatology. 59, 4, p. 1273-1282

    Research output: Contribution to journalArticle

  8. 2012
  9. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice

    Volarevic, V., Milovanovic, M., Ljujic, B., Pejnovic, N., Arsenijevic, N., Ulf Nilsson, Leffler, H. & Lukic, M. L., 2012, In : Hepatology. 55, 6, p. 1954-1964

    Research output: Contribution to journalArticle

  10. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents

    Santoro, N., Zhang, C. K., Zhao, H., Pakstis, A. J., Kim, G., Kursawe, R., Dykas, D. J., Bale, A. E., Giannini, C., Pierpont, B., Shaw, M. M., Leif Groop & Caprio, S., 2012, In : Hepatology. 55, 3, p. 781-789

    Research output: Contribution to journalArticle

  11. 2011
  12. IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection

    Moghaddam, A., Melum, E., Reinton, N., Ring-Larsen, H., Verbaan, H., Bjoro, K. & Dalgard, O., 2011, In : Hepatology. 53, 3, p. 746-754

    Research output: Contribution to journalArticle

  13. The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: A viable mouse model for mitochondrial hepatopathy.

    Levéen, P., Kotarsky, H., Mörgelin, M., Karikoski, R., Eskil Elmer & Vineta Fellman, 2011, In : Hepatology. 53, 2, p. 437-447

    Research output: Contribution to journalArticle

  14. 2010
  15. Il28B Genetic Variation And Treatment Response In Patients With Hcv Genotype 3 Infection

    Dalgard, O., Moghaddam, A., Verbaan, H., Ring-Larsen, H., Bjoro, K. & Melum, E., 2010, In : Hepatology. 52, 4, p. 898

    Research output: Contribution to journalPublished meeting abstract

  16. Incidence and Prevalence of Primary Sclerosing Cholangitis in a Defined Adult Population in Sweden

    Lindkvist, B., de Valle, M. B., Bo Gullberg & Bjornsson, E., 2010, In : Hepatology. 52, 2, p. 571-577

    Research output: Contribution to journalArticle

  17. Increased Factor Viii Activity In Portal Vein Thrombosis And Budd-Chiari Syndrome

    Rajani, R., Bergquist, A., Melin, T., Friis-Liby, I., Kapraali, M., Werner, M., Sangfelt, P., Wallerstedt, S., Lindahl, T. L. & Almer, S., 2010, In : Hepatology. 52, 4, p. 1217

    Research output: Contribution to journalPublished meeting abstract

  18. Minocycline Sensitizes Rodent and Human Liver Mitochondria to the Permeability Transition: Implications for Toxicity in Liver Transplantation

    Månsson, R., Morota, S., Magnus Hansson, Sonoda, I., Yasuda, Y., Shimazu, M., Sugiura, A., Yanagi, S., Miura, H., Uchino, H. & Eskil Elmer, 2010, In : Hepatology. 51, 1, p. 347-348

    Research output: Contribution to journalLetter

  19. 2009
  20. Low-To-Moderate Alcohol Consumption has no Impact on Antiviral Response to Combination Therapy In Hcv Patients with Genotype 2 or 3

    Carvalho-Filho, R. J., Verbaan, H., Bjoro, K., Ring-Larsen, H. & Dalgard, O., 2009, In : Hepatology. 50, 4, p. 819

    Research output: Contribution to journalPublished meeting abstract

  21. 2008
  22. IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS

    Dalgard, O., Verbaan, H., Ring-Larsen, H. & Bjoro, K., 2008, In : Hepatology. 48, 4, p. 1875

    Research output: Contribution to journalPublished meeting abstract

  23. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

    Dalgard, O., Bjoro, K., Ring-Larsen, H., Bjornsson, E., Holberg-Petersen, M., Skovlund, E., Reichard, O., Myrvang, B., Sundelof, B., Ritland, S., Hellum, K., Fryden, A., Florholmen, J. & Verbaan, H., 2008, In : Hepatology. 47, 1, p. 35-42

    Research output: Contribution to journalArticle

  24. 2006
  25. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation

    Hanne Prytz, Keiding, S., Bjornsson, E., Broome, U., Ahner, S., Castedal, M. & Munk, O. L., 2006, In : Hepatology. 44, 6, p. 1572-1580

    Research output: Contribution to journalArticle

  26. 2005
  27. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

    Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspe, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D. G., Okamoto, H., Pawlotsky, J. M., Penin, F. O., Sablon, E., Tadasu, S. I., Stuyver, L., Thiel, H. J., Viazov, S. & 2 others, Weiner, A. & Anders Widell, 2005, In : Hepatology. 42, 4, p. 962-973

    Research output: Contribution to journalArticle

  28. 2004
  29. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha(1)-antitrypsin.

    Sabina Janciauskiene, Eriksson, S., Callea, F., Mallya, M., Zhou, A., Seyarna, K., Hata, S. & Lomas, D. A., 2004, In : Hepatology. 40, 5, p. 1203-1210

    Research output: Contribution to journalArticle

  30. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice

    Oe, S., Lemmer, ER., Conner, EA., Factor, VM., Levéen, P., Jonas Larsson, Stefan Karlsson & Thorgeirsson, SS., 2004, In : Hepatology. 40, 5, p. 1098-1105

    Research output: Contribution to journalArticle

  31. 2003
  32. Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer.

    Wadström, T., Abu Al-Soud, W., Ljungh, Å., Nilsson, H-O. & Stenram, U., 2003, In : Hepatology. 38, 2, p. 532-533

    Research output: Contribution to journalLetter

  33. 2001
  34. Impact of selective inactivation of transforming growth factor-beta type II receptor gene (TGFBR2) during viral hepatitis

    Lemmer, E. R., Conner, E. A., Leveen, P., Factor, V. M., Tsai, T. L., Huh, C. G., Stefan Karlsson & Thorgeirsson, S. S., 2001, In : Hepatology. 34, 4, Suppl. 2, p. 491A-491A

    Research output: Contribution to journalArticle

  35. 1997
  36. 1994
  37. Laser-induced Ala Photodynamic Therapy In the Treatment of Rat-liver Tumor

    Liu, D. L., Katarina Svanberg, Wang, I., Andersson-Engels, S., Stenram, U. & Sune Svanberg, 1994, In : Hepatology. 20, 4

    Research output: Contribution to journalArticle

  38. 1993
  39. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

    Zhang, Y-Y., Hansson, B-G., Kuo, L. S., Anders Widell & Nordenfelt, E., 1993, In : Hepatology. 17, 4, p. 538-544

    Research output: Contribution to journalArticle